Wilson Sonsini Goodrich & Rosati advised Chroma Medicine on the deal.Chroma Medicine, a new genomic medicine company pioneering epigenetic editing, launched with $125 million in financing….
Chroma Medicine’s $125 Million Financing


Wilson Sonsini Goodrich & Rosati advised Chroma Medicine on the deal.Chroma Medicine, a new genomic medicine company pioneering epigenetic editing, launched with $125 million in financing….
…